MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s stock price hit a new 52-week low during trading on Monday . The company traded as low as C$0.06 and last traded at C$0.07, with a volume of 20035 shares changing hands. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The firm has a market cap of C$27.35 million, a PE ratio of -2.17 and a beta of 0.31. The stock has a 50-day moving average price of C$0.07 and a 200 day moving average price of C$0.07. The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10.
MediPharm Labs (TSE:LABS – Get Free Report) last issued its quarterly earnings results on Thursday, November 13th. The company reported C($0.01) earnings per share (EPS) for the quarter. MediPharm Labs had a negative return on equity of 24.41% and a negative net margin of 30.56%.The business had revenue of C$11.45 million during the quarter. Research analysts forecast that MediPharm Labs Corp. will post -0.04 earnings per share for the current year.
MediPharm Labs Company Profile
MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4.
Featured Stories
- Five stocks we like better than MediPharm Labs
- How Can Investors Benefit From After-Hours Trading
- If D-Wave Is Too Risky, Consider These 3 Quantum ETFs for Diversification
- Why is the Ex-Dividend Date Significant to Investors?
- NVIDIA’s 13F Reveals 2 Q3 Winners—And 1 Painful Miss
- Profitably Trade Stocks at 52-Week Highs
- Why Silver Beat Gold and the S&P in 2025—And What Comes Next
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
